Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

In vitro studies suggest potential use of novel IKK2 inhibitor in glomerulonephritis

Nov. 22, 2006

Novel monoclonal antibodies for renal diseases emerge from Lilly R&D

Nov. 21, 2006

Recent Bayer patent discloses novel treatment strategy for BPH

Nov. 14, 2006

Novel agents for fibrotic disorders patented

Nov. 2, 2006

Novel alpha1A/1D-adrenoceptor antagonists reported by Janssen

Oct. 31, 2006

Lilly to acquire ICOS

Oct. 19, 2006

Canadian clearance for phase I study of PRX-302 in BPH

Oct. 19, 2006

Fresenius to acquire phosphate binder business from Nabi

Oct. 17, 2006

NDA filed for Sanctura XR in overactive bladder

Oct. 16, 2006

Otsuka launching Physuline in Japan

Oct. 16, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...